Catheter-associated Nocardia higoensis bacteremia in a child with acute lymphocytic leukemia

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 469-471

  Watson Jr , Michael E ^a   Estabrook, Michele M ^a   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ASPARAGINASE MACROGOL; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; LINEZOLID; MERCAPTOPURINE; METHOTREXATE; MINOCYCLINE; MOXIFLOXACIN; RNA 16S; SULFADIAZINE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; B CELL LEUKEMIA; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD LEUKEMIA; FEVER; GENE SEQUENCE; GENOTYPE; HUMAN; INCUBATION TIME; INFANT; JAPAN; LEUKOCYTE COUNT; LUNG INFECTION; MALE; MYCOBACTERIUM; NOCARDIA; NOCARDIA HIGOENSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; INFANT; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; NOCARDIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

NOCARDIA HIGOENSIS;

EID: 78650890419     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01816-10     Document Type: Article

References (17)

1. Brown-Elliott, B. A., J. M. Brown, P. S. Conville, and R. J. Wallace, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
2. Christidou, A., et al. 2004. Fatal Nocardia farcinica bacteremia in a patient with lung cancer. Diagn. Microbiol. Infect. Dis. 50:135-139.
3. Clinical Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline, MM18-A. Clinical Laboratory Standards Institute, Wayne, PA.
4. Conville, P. S., et al. 2004. Nocardia kruczakiae sp. nov., a pathogen in immunocompromised patients and a member of the "N. nova complex." J. Clin. Microbiol. 42:5139-5145.
5. Feng, Y. H., W. T. Huang, and C. J. Tsao. 2004. Venous access port-related Nocardia bacteremia with successful short-term antibiotics treatment. J. Chin. Med. Assoc. 67:416-418.
6. Kageyama, A., et al. 2004. Nocardia shimofusensis sp. nov., isolated from soil, and Nocardia higoensis sp. nov., isolated from a patient with lung nocardiosis in Japan. Int. J. Syst. Evol. Microbiol. 54:1927-1931.
7. Kontoyiannis, D. P., K. L. Jacobson, E. E. Whimbey, K. V. Rolston, and I. I. Raad. 2000. Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin. Infect. Dis. 31:617-618.
8. Kontoyiannis, D. P., K. Ruoff, and D. C. Hooper. 1998. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine (Baltimore) 77:255-267.
9. Lai, C. H., et al. 2004. Port-A catheter-associated Nocardia bacteremia detected by gallium inflammation scan: a case report and literature review. Scand. J. Infect. Dis. 36:775-777.
10. Lui, W. Y., A. C. Lee, and T. L. Que. 2001. Central venous catheter-associated Nocardia bacteremia. Clin. Infect. Dis. 33:1613-1614.
11. Maraki, S., et al. 2006. Nocardia cyriacigeorgica pleural empyema in an immunocompromised patient. Diagn. Microbiol. Infect. Dis. 56:333-335.
12. Murray, P. R. (ed.). 2007. Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
13. Naik, S., R. Mateo-Bibeau, M. Shinnar, M. Mahal, and R. Freudenberger. 2007. Successful treatment of Nocardia nova bacteremia and multilobar pneumonia with clarithromycin in a heart transplant patient. Transplant Proc. 39:1720-1722.
14. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. NCCLS, Wayne, PA.
15. Torres, H. A., et al. 2002. Nocardiosis in cancer patients. Medicine (Baltimore) 81:388-397.
16. Wallace, R. J., Jr., and L. C. Steele. 1988. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn. Microbiol. Infect. Dis. 9:155-166.
17. Wallace, R. J., Jr., L. C. Steele, G. Sumter, and J. M. Smith. 1988. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob. Agents Chemother. 32:1776-1779.